This study can be leveraged to support new ACE2 fusion protein designs, purification strategies, and formulation studies to facilitate the manufacture of ACE2-Fc and ACE2(NN)-Fc for potential studies related to the COVID-19 public health emergency, and potentially other ACE2-dependent coronavirus diseases. Here, ACE2 is linked to COVID-19.